Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
Almejún MB, Borge M, Colado A, Elías EE, Podaza E, Risnik D, De Brasi CD, Stanganelli C, Slavutsky I, Cabrejo M, Fernández-Grecco H, Bezares RF, Cranco S, Burgos RÁ, Sánchez-Ávalos JC, Oppezzo P, Giordano M, Gamberale R. Almejún MB, et al. Among authors: oppezzo p. Haematologica. 2017 Jul;102(7):e257-e260. doi: 10.3324/haematol.2017.167353. Epub 2017 Mar 30. Haematologica. 2017. PMID: 28360148 Free PMC article. No abstract available.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Risnik D, Colado A, Podaza E, Almejún MB, Elías EE, Bezares RF, Fernández-Grecco H, Seija N, Oppezzo P, Borge M, Gamberale R, Giordano M. Risnik D, et al. Among authors: oppezzo p. Cancer Immunol Immunother. 2020 May;69(5):813-824. doi: 10.1007/s00262-020-02513-y. Epub 2020 Feb 13. Cancer Immunol Immunother. 2020. PMID: 32055920 Free PMC article.
CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
Nannini PR, Borge M, Mikolaitis VC, Abreu C, Morande PE, Zanetti SR, Oppezzo P, Palacios F, Ledesma I, Bezares RF, Giordano M, Gamberale R. Nannini PR, et al. Among authors: oppezzo p. Eur J Haematol. 2011 Jul;87(1):80-6. doi: 10.1111/j.1600-0609.2011.01613.x. Eur J Haematol. 2011. PMID: 21443542
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
Borge M, Remes Lenicov F, Nannini PR, de los Ríos Alicandú MM, Podaza E, Ceballos A, Fernández Grecco H, Cabrejo M, Bezares RF, Morande PE, Oppezzo P, Giordano M, Gamberale R. Borge M, et al. Among authors: oppezzo p. J Immunol. 2014 Sep 15;193(6):3165-74. doi: 10.4049/jimmunol.1400547. Epub 2014 Aug 15. J Immunol. 2014. PMID: 25127862
Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia.
Morande PE, Borge M, Abreu C, Galletti J, Zanetti SR, Nannini P, Bezares RF, Pantano S, Dighiero G, Oppezzo P, Gamberale R, Giordano M. Morande PE, et al. Among authors: oppezzo p. Leuk Lymphoma. 2015 Apr;56(4):1115-22. doi: 10.3109/10428194.2014.957205. Epub 2015 Jan 21. Leuk Lymphoma. 2015. PMID: 25156469
Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia.
Stanganelli C, Torres DC, Ortega C, Sotelo N, Márquez ME, Segges P, Muniz MTC, Bigni RS, Campregher PV, Sabino A, Gomes CP, Lopes Ferrari deChauffaille ML, Arrais Rodrigues C, Yamamoto M, Abdelhay E, Cabrera J, Deglesne PA, López JL, Galvano C, Krzywinski A, Bezares R, Lang C, Zanella L, Agriello E, Cabrejo M, Gabús R, Dighiero G, Oppezzo P, Hassan R, Slavutsky I; Latin American Group of Chronic Lymphocytic Leukemia (LAG-CLL). Stanganelli C, et al. Among authors: oppezzo p. Hematol Oncol. 2019 Dec;37(5):644-648. doi: 10.1002/hon.2661. Epub 2019 Oct 31. Hematol Oncol. 2019. PMID: 31373034 No abstract available.
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.
Stanganelli C, Torres DC, Ortega C, Márquez ME, Remedi V, Cabrera J, Mardaraz C, Galvano C, Krzywinski A, Lang C, Zanella L, Agriello E, Bezares R, Pavlovsky A, Pavlovsky MA, Oppezzo P, Slavutsky I. Stanganelli C, et al. Among authors: oppezzo p. Ann Hematol. 2022 Feb;101(2):341-348. doi: 10.1007/s00277-021-04703-9. Epub 2021 Oct 28. Ann Hematol. 2022. PMID: 34713310
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.
Prieto D, Seija N, Uriepero A, Souto-Padron T, Oliver C, Irigoin V, Guillermo C, Navarrete MA, Inés Landoni A, Dighiero G, Gabus R, Giordano M, Oppezzo P. Prieto D, et al. Among authors: oppezzo p. Br J Haematol. 2018 Aug;182(4):521-525. doi: 10.1111/bjh.15427. Epub 2018 Jun 28. Br J Haematol. 2018. PMID: 29953583 Free article.
60 results